Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Second Primary × Bupropion × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 3 Tobacco Use Disorder 3 Obesity 3 Head and Neck Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Smoking Cessation 2 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Overweight 2 Ovarian Neoplasms 2 Oropharyngeal Neoplasms 2 Nasopharyngeal Neoplasms 2 Mouth Neoplasms 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Laryngeal Neoplasms 2 Kidney Neoplasms 2 Hypopharyngeal Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 cyclopia sequence 1 Vulvar Neoplasms 1

Interventions

Drug Therapy 3 Temozolomide 2 Radiotherapy 2 Radiosurgery 2 Leucovorin 2 Irinotecan 2 Fluorouracil 2 sacubitril and valsartan sodium hydrate drug combination 1 icotinib 1 dostarlimab 1 beta Carotene 1 avelumab 1 alpha-Tocopherol 1 Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Thalidomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Semen Analysis 1 Registries 1 Probiotics 1 Patient Reported Outcome Measures 1 Panitumumab 1 Nicotine Chewing Gum 1 Myofascial Release Therapy 1 Megestrol Acetate 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04634071 2026-02-02

TTOP

University of Kentucky

Phase 2 Completed

Smoking Cessation, Neoplasms, Second Primary, Behavior, Addictive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡